510(k) · Cleared
Recalled · Class II · 2026Medicalyte (R) Bicarbonate Powder (36.83X), Medicalyte (R) Bicarbonate Powder (45X), Medicalyte (R) Bicarbonate Powder (35X
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dialysis Medical Solutions, LLC · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Cleared on Apr 3, 2014 as substantially equivalent to K954527 (Rockwell Medical Supply, 1996) and 2 other predicates after a 339-day review. Its family tree reaches back 1 generation to 1985. 4 later devices descend from it. It has been recalled once.
- Decided
- Apr 3, 2014
- Review
- 339 days
- Class
- Class II
- Product code
- KPO
- Recalls
- 1
- Predicates
- 3
Its longest line of descent runs back 1 generation to K843963 (1985). 3 ancestors in all. 4 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK843963 Dialysate Concentrate for Hemodialysis-Liquid/PowdRenal Systems, Inc. · 1985 · Recalled
- This deviceK131202 Medicalyte (R) Bicarbonate Powder (36.83X), Medicalyte (R)…Dialysis Medical Solutions, LLC · 2014
- Descendant · cites it directly · 2 of its ownK171750 Citric Complete Dry Citric Acid (45X)Dimesol USA, LLC · 2018 · Recalled
- Descendant · 2 generations on · 1 of its ownK223431 Citric Complete Liquid Citric Acid ConcentrateNipro Renal Solutions USA, Corp. · 2023 · Recalled
- Descendant · 3 generations on · 0 of its ownK260799 Nipro Dry Acid Concentrate MixerNipro Technical Solutions, Incoporated · 2026
- Descendant · cites it directly · 0 of its ownK193155 Nipro Dry Complete Dry Acid Concentrate for HemodialysisNipro Renal Solutions USA, Corp. · 2020
Most influential descendants
Showing 4 of 4 · See all- K171750Citric Complete Dry Citric Acid (45X)Dimesol USA, LLC · 2018 · cites it directly2descendants
- K223431Citric Complete Liquid Citric Acid ConcentrateNipro Renal Solutions USA, Corp. · 2023 · 2 generations on1descendant
- K260799Nipro Dry Acid Concentrate MixerNipro Technical Solutions, Incoporated · 2026 · 3 generations on0descendants
- K193155Nipro Dry Complete Dry Acid Concentrate for HemodialysisNipro Renal Solutions USA, Corp. · 2020 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K843963 | Dialysate Concentrate for Hemodialysis-Liquid/Powd | Renal Systems, Inc. | 1985 | 1 |
| 0 (this device) | K131202 | Medicalyte (R) Bicarbonate Powder (36.83X), Medicalyte (R) Bicarbonate Powder… | Dialysis Medical Solutions, LLC | 2014 | — |
| +1 | K171750 | Citric Complete Dry Citric Acid (45X) | Dimesol USA, LLC | 2018 | 2 |
| +2 | K223431 | Citric Complete Liquid Citric Acid Concentrate | Nipro Renal Solutions USA, Corp. | 2023 | 1 |
| +3 | K260799 | Nipro Dry Acid Concentrate Mixer | Nipro Technical Solutions, Incoporated | 2026 | — |
| +1 | K193155 | Nipro Dry Complete Dry Acid Concentrate for Hemodialysis | Nipro Renal Solutions USA, Corp. | 2020 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 2002 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2018 | 1 | 0 |
| 2020 | 1 | 0 |
| 2023 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KPO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KPO device
- #1 K233159 pureFLOW 402, pureFLOW 400, pureFLOW 406…score 14.5 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K954527 | Rockwell Medical Supply LLC Hemodialysis Concentrate Solutions & PowdersSummary page 2…5 10(K) SUMMARY UNDER 21 CFR 807.92 C. Legally Marketed Predicate Device Rockwell Medical Supply RenalPure® Powder Bicarbonate for Hemodialysis (K954527) Medivator Inc. Renasol®@ and Centrisol® Bicarbonate Concentrate Powder (K843963) Di-Chem, Inc. Hemo-Lyte Dry S… | 1996 |
| * | K843963 | Dialysate Concentrate for Hemodialysis-Liquid/PowdSummary page 2…Rockwell Medical Supply RenalPure® Powder Bicarbonate for Hemodialysis (K954527) Medivator Inc. Renasol®@ and Centrisol® Bicarbonate Concentrate Powder (K843963) Di-Chem, Inc. Hemo-Lyte Dry Sodium Bicarbonate-Chloride Concentrate and Dry Sodium Bicarbonate Concentrate (KO… | 1985 |
| * | K012328 | Hemo-Lyte Hemodialysis Grade Sodium Bicarbonate PowderSummary page 6…ate Concentrate Powder (K843963) predicate devices, and the Di-Chem, Inc. Hemo-Lyte Dry Sodium Bicarbonate-Chloride Concentrate and Dry Sodium Bicarbonate Concentrate (KO012328) predicate devices, and are therefore expected to be as safe, as effective, and perform as well as the predicate devices. 510O(… | 2002 |
What descends from it? (4)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Aug 5, 2026 | Class II | Z-3134-2026 | Process control | Hemodialysis concentrates contain high endotoxin levels |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All KPO devicesKPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · KPO
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · KPO
112in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KPO
6in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · KPO
95in 2025
MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 5 | 5 |
| 2008 | 2 | — | 2 | 8 |
| 2009 | 1 | — | 1 | 3 |
| 2010 | 0 | — | 0 | 107 |
| 2011 | 1 | — | 2 | 223 |
| 2012 | 2 | — | 10 | 70 |
| 2013 | 1 | — | 0 | 3,897 |
| 2014 | 2 | — | 0 | 15,916 |
| 2015 | 1 | — | 3 | 8,340 |
| 2016 | 1 | — | 1 | 240 |
| 2017 | 3 | 192 | 1 | 80 |
| 2018 | 2 | — | 11 | 97 |
| 2019 | 0 | — | 1 | 79 |
| 2020 | 5 | 270 | 31 | 244 |
| 2021 | 1 | — | 0 | 63 |
| 2022 | 2 | — | 2 | 25 |
| 2023 | 3 | 263 | 0 | 59 |
| 2024 | 3 | 112 | 1 | 259 |
| 2025 | 2 | — | 6 | 95 |
| 2026 | 2 | — | 9 | — |
What is it indicated for?
For DB-203; DB-204; DB-205: This product is formulated to be used in conjunction with MedicaPure® liquid acid concentrate or equivalent in a 36.83x three-stream artificial kidney (hemodialysis) machine for use in treating a patient in need of hemodialysis. For DB-206; DB-207; DB-208: This product is formulated to be used in conjunction with MedicaPure® liquid acid concentrate or equivalent in a 45x three-stream artificial kidney (hemodialysis) machine…
Read the full statement (114 words)
For DB-203; DB-204; DB-205:
This product is formulated to be used in conjunction with MedicaPure® liquid acid concentrate or equivalent in a 36.83x three-stream artificial kidney (hemodialysis) machine for use in treating a patient in need of hemodialysis.
For DB-206; DB-207; DB-208:
This product is formulated to be used in conjunction with MedicaPure® liquid acid concentrate or equivalent in a 45x three-stream artificial kidney (hemodialysis) machine for use in treating a patient in need of hemodialysis.
For DB-209; DB-210; DB-211:
This product is formulated to be used in conjunction with MedicaPure® liquid acid concentrate or equivalent in a 35x three-stream artificial kidney (hemodialysis) machine for use in treating a patient in need of hemodialysis.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K131202 · printed Nov 4, 2026
Cite this page
510(k) Report. “K131202: Medicalyte (R) Bicarbonate Powder (36.83X), Medicalyte (R) Bicarbonate Powder (45X), Medicalyte (R) Bicarbonate Powder (35X.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K131202
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026